Synthetic MRI with quantitative mappings for identifying receptor status, proliferation rate, and molecular subtypes of breast cancer
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Synthetic MRI with quantitative mappings for identifying receptor status, proliferation rate, and molecular subtypes of breast cancer
Authors
Keywords
Synthetic magnetic resonance imaging, Receptor status, Proliferation rate, Molecular subtype, Breast cancer
Journal
EUROPEAN JOURNAL OF RADIOLOGY
Volume 148, Issue -, Pages 110168
Publisher
Elsevier BV
Online
2022-01-20
DOI
10.1016/j.ejrad.2022.110168
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Utility of synthetic MRI in predicting the Ki-67 status of oestrogen receptor-positive breast cancer: a feasibility study
- (2020) M. Matsuda et al. CLINICAL RADIOLOGY
- Improved discrimination of molecular subtypes in invasive breast cancer: Comparison of multiple quantitative parameters from breast MRI
- (2020) Siyao Du et al. MAGNETIC RESONANCE IMAGING
- Diffusion-weighted imaging (DWI) with apparent diffusion coefficient (ADC) mapping as a quantitative imaging biomarker for prediction of immunohistochemical receptor status, proliferation rate, and molecular subtypes of breast cancer
- (2019) Joao V. Horvat et al. JOURNAL OF MAGNETIC RESONANCE IMAGING
- An MRI-based Radiomics Classifier for Preoperative Prediction of Ki-67 Status in Breast Cancer
- (2018) Cuishan Liang et al. ACADEMIC RADIOLOGY
- Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update
- (2018) Antonio C. Wolff et al. JOURNAL OF CLINICAL ONCOLOGY
- Intravoxel Incoherent Motion and Quantitative Non-Gaussian Diffusion MR Imaging: Evaluation of the Diagnostic and Prognostic Value of Several Markers of Malignant and Benign Breast Lesions
- (2018) Mami Iima et al. RADIOLOGY
- Conventional and synthetic MRI in multiple sclerosis: a comparative study
- (2017) Wolfgang Krauss et al. EUROPEAN RADIOLOGY
- Multiparametric diffusion-weighted imaging in breast lesions: Association with pathologic diagnosis and prognostic factors
- (2017) Shiteng Suo et al. JOURNAL OF MAGNETIC RESONANCE IMAGING
- Breast Cancer Heterogeneity: MR Imaging Texture Analysis and Survival Outcomes
- (2017) Jae-Hun Kim et al. RADIOLOGY
- MRI texture analysis in differentiating luminal A and luminal B breast cancer molecular subtypes - a feasibility study
- (2017) Kirsi Holli-Helenius et al. BMC MEDICAL IMAGING
- Perfusion Parameters in Dynamic Contrast-enhanced MRI and Apparent Diffusion Coefficient Value in Diffusion-weighted MRI:
- (2016) Hyun Sil Lee et al. ACADEMIC RADIOLOGY
- Correlation of the SUVmax of FDG-PET and ADC values of diffusion-weighted MR imaging with pathologic prognostic factors in breast carcinoma
- (2016) Kazuhiro Kitajima et al. EUROPEAN JOURNAL OF RADIOLOGY
- Differences in morphological features and minimum apparent diffusion coefficient values among breast cancer subtypes using 3-tesla MRI
- (2016) Fumi Kato et al. EUROPEAN JOURNAL OF RADIOLOGY
- Computerized Image Analysis for Identifying Triple-Negative Breast Cancers and Differentiating Them from Other Molecular Subtypes of Breast Cancer on Dynamic Contrast-enhanced MR Images: A Feasibility Study
- (2014) Shannon C. Agner et al. RADIOLOGY
- Correlations between apparent diffusion coefficient values of invasive ductal carcinoma and pathologic factors on diffusion-weighted MRI at 3.0 Tesla
- (2013) Sung Hee Park et al. JOURNAL OF MAGNETIC RESONANCE IMAGING
- Molecular subclasses of breast cancer: how do we define them? The IMPAKT 2012 Working Group Statement
- (2012) S. Guiu et al. ANNALS OF ONCOLOGY
- Predictive value of breast cancer molecular subtypes in Chinese patients with four or more positive nodes after postmastectomy radiotherapy
- (2012) San-Gang Wu et al. BREAST
- Correlations between diffusion-weighted imaging and breast cancer biomarkers
- (2012) Laura Martincich et al. EUROPEAN RADIOLOGY
- Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011
- (2011) A. Goldhirsch et al. ANNALS OF ONCOLOGY
- Lymphatic and blood vessels in basal and triple-negative breast cancers: characteristics and prognostic significance
- (2011) Rabab A A Mohammed et al. MODERN PATHOLOGY
- FDG PET/CT and diffusion-weighted imaging for breast cancer: prognostic value of maximum standardized uptake values and apparent diffusion coefficient values of the primary lesion
- (2010) Masatoyo Nakajo et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer
- (2010) M. Elizabeth H. Hammond et al. JOURNAL OF CLINICAL ONCOLOGY
- Diffusion-weighted MR Imaging: Pretreatment Prediction of Response to Neoadjuvant Chemotherapy in Patients with Breast Cancer
- (2010) Sang Hee Park et al. RADIOLOGY
- Significantly higher levels of vascular endothelial growth factor (VEGF) and shorter survival times for patients with primary operable triple-negative breast cancer
- (2009) B. K. Linderholm et al. ANNALS OF ONCOLOGY
- Diffusion-weighted imaging of breast cancer: Correlation of the apparent diffusion coefficient value with prognostic factors
- (2009) Sung Hun Kim et al. JOURNAL OF MAGNETIC RESONANCE IMAGING
- Estrogen Receptor, Progesterone Receptor, HER-2, and Response to Postmastectomy Radiotherapy in High-Risk Breast Cancer: The Danish Breast Cancer Cooperative Group
- (2008) Marianne Kyndi et al. JOURNAL OF CLINICAL ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started